Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
– 2023 marked byCeapro’sachievement of key milestones and progress toward its next phase of growth
Source: eagletribune.com
Corealis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Corealis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Corealis Inc Today - Breaking & Trending Today
Ceapro Inc. Reports 2023 Third Quarter and Nine-Month
– Product development focused on the production of powder formulations of oat beta glucan and avenanthramides for cosmeceuticals market – Technology...
Source: globenewswire.com
Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights
– Product development focused on the production of powder formulations of oat beta glucan and avenanthramides for cosmeceuticals market – Technology development focused on the PGX pilot...
Source: marketscreener.com
Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
? 2022 marks Ceapro's best performance in Company history with record sales of $18,800,000 compared to $17,200,000 for 2021, representing a 10% increase year over year ? Net profit after tax of $4,400,000 for the full year of 2022 compared to...
Source: lelezard.com
Ceapro Inc. Reports Record 2022 Second Quarter and
– Company boasts highest second quarter sales to date; Q2 2022 sales of $5,500,000 vs $4,409,000 in Q2 2021, a 25% increase – YTD Sales increased 28% vs...
Source: globenewswire.com